Global Digital Therapeutics Market Analysis by Industry Players: Otsuka Pharmaceutical, Co. Ltd.

The recently published analytical report description by renowned consulting, data analytics, and market research firm, Markntel Advisors describes, growth factors, prominent players' potential & recent achievements and forecasts their expected market influence in the upcoming years. The concerned report description demonstrates the operation of the players including new launching of innovative products, strategic collaborations, or partnerships, that bolster the growth of the Global Digital Therapeutics market. One of the leading market players Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc., announced that the US Food and Drug Administration (FDA) has cleared Rejoyn™ (developed as CT-152), the first prescription digital therapeutic authorized for the treatment of major depressive disorder (MDD).

The report further comprises "Global Digital Therapeutics Market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30. The predicted market growth is driven by the high healthcare costs, which have increased the adoption of digital therapeutic solutions that offer remote & scalable interventions to prevent or manage conditions, thus reducing the need for expensive in-person care.

Leading Segmentation Analysis Based On Product, Application, and Region

The Global Digital Therapeutics market is segmented into four segments, applications, business models, products, and region

• Based on Product, the market is segmented into Software, and Hardware

Based on Application, the market is segmented into Preventive (Pre-diabetes, obesity, smoking cessation, and others) and Treatment (Cardiovascular Diseases, Central Nervous System Diseases, Diabetes, Musculoskeletal Diseases, and Others)

Based on Business Model, the market is segmented into Business-to-Consumer [B2C], and Business-to-Business [B2B]

Based on Region, the market is segmented into North America South America Europe the Middle East & Africa Asia-Pacific

Key Takeaways

• Study Period: Global Digital Therapeutics market report historical data – 2019-22, Base year –2023, and Forecast Period- 2024-30.
• Market Growth: The Global Digital Therapeutics market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30.

• Growth Driver: The Global Digital Therapeutics market is expected to expand with the Increasing Prevalence of Preventable Chronic Diseases

• Growth Challenge: The Global Digital Therapeutics market is expected to be hampered owing to the Data Privacy & Security
• By Product: The Software segment led the market segment owing to the increased prevalence of chronic & infectious diseases necessitating the adoption of scalable & cost-effective solutions, such as digital therapeutics.
• By Application: The Treatment segment led the market segment as the increasing number of patients with various diseases & disorders, including neurological diseases, diabetes, cardiovascular diseases, etc.

Frequently Asked Questions (FAQs)-

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What leading factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & Global Digital Therapeutics adoption?
5. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

Jack Daniel Email: sales@marknteladvisors.com Phone: +1 628 895 8081 +91 120 4268433.